Skip to main content
Clinical Trials/EUCTR2005-001518-42-IT
EUCTR2005-001518-42-ITActive, not recruitingNot Applicable

A six.month, prospective,multicenter, open label, parallel, randomized study of the safety, tolerability and efficacy of myfortic with Simulect

OVARTIS FARMA0 sites288 target enrollmentStarted: March 23, 2006Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
288

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Investigators

Similar Trials

Active, not recruiting
Not Applicable
A six-month, prospective, multicenter, open label, parallel, randomized study of the safety, tolerability and efficacy of myfortic® (ERL080) with Simulect®, corticosteroids and two different levels of tacrolimus in de novo renal transplant recipients
EUCTR2005-001518-42-ESovartis Farmaceútica S.A288
Active, not recruiting
Not Applicable
PALMFlexS: Paliperidone Palmitate Flexible Dosing in SchizophreniaMedDRA version: 14.0Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersSchizophrenia
EUCTR2009-018022-30-DKJanssen-Cilag International N.V.1,000
Active, not recruiting
Not Applicable
PALMFlexS: Paliperidone Palmitate Flexible Dosing in SchizophreniaMedDRA version: 17.0Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersSchizophrenia
EUCTR2009-018022-30-PTJanssen-Cilag International N.V.1,000
Active, not recruiting
Not Applicable
A 6-month, open label, prospective, multicenter, international, exploratory study of a transition to flexibly dosed paliperidone palmitate in patients with schizophrenia previously unsuccessfully treated with oral or long-acting injectable antipsychotics. - PALMFlexSMedDRA version: 12.1Level: LLTClassification code 10039626Term: SchizophreniaSchizophrenia
EUCTR2009-018022-30-HUJanssen-Cilag International N.V.1,000
Active, not recruiting
Not Applicable
PALMFlexS: Paliperidone Palmitate Flexible Dosing in SchizophreniaMedDRA version: 14.1Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersSchizophrenia
EUCTR2009-018022-30-SEJanssen-Cilag International N.V.1,000
A six.month, prospective,multicenter, open... | Clinical Trial